ULTIMATE II Archives - Medical Conferences

Ublituximab versus teriflunomide in relapsing MS patients

Presented By

Prof. Lawrence Steinman, Stanford University, CA, USA

Trial

Phase 3, ULTIMATE I; ULTIMATE II

Conference

AAN 2022

Type

Peer-reviewed article

2 June 2022 16:07

AAN 2022 Highlights Podcast

Presented By

Robert van den Heuvel, Medicom

Conference

AAN 2022

19 April 2022 22:42

Ublituximab meets primary endpoint for relapsing MS

Presented By

Prof. Lawrence Steinman, Stanford University, CA, USA

Trial

Phase 3, ULTIMATE I, ULTIMATE II

Conference

ECTRIMS 2021

Type

Peer-reviewed article

9 December 2021 14:33

ECTRIMS 2021 Highlights Podcast

Presented By

Dr Rachel Giles, Medicom

Trial

COMBAT-MS, SAkuraSky, SAkuraStar, ULTIMATE I and II, ORATORIO

Conference

ECTRIMS 2021

1 November 2021 08:32

Positive results from ublituximab versus teriflunomide

Trial

Phase 3, ULTIMATE I, ULTIMATE II

Conference

EAN 2021

Type

Peer-reviewed article

18 August 2021 10:35

Ublituximab versus teriflunomide in relapsing MS

Trial

Phase 2, ULTIMATE I, ULTIMATE II

Conference

AAN 2021

Type

Peer-reviewed article

16 June 2021 11:50